3.0.0
685
2025-11-01T08:05:26Z
2025-11-01T08:05:26Z
House
H
HR
2025-01-23
119
https://www.congress.gov/bill/119th-congress/house-bill/685
[Congressional Record Volume 171, Number 14 (Thursday, January 23, 2025)][House][Pages H388-H389]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. LATTA:H.R. 685.Congress has the power to enact this legislation pursuantto the following:The Constitution grants of powers to Congress under ArticleI, Section 8, Clause 18: To[[Page H389]]make all Laws which shall be necessary and proper forcarrying into Execution the foregoing Powers, and all otherPowers vested by this Constitution in the Government of theUnited States, or in any Department or Officer thereof.
- hsif00
Energy and Commerce Committee
House
Standing
  - Referred To
2025-01-23T15:04:35Z
- 2025-01-23
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2025-01-23
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2025-01-23
Introduced in House
IntroReferral
1000
9
Library of Congress
- L000566
Rep. Latta, Robert E. [R-OH-5]
Robert
Latta
R
OH
E.
5
N
- R000603
Rep. Rouzer, David [R-NC-7]
David
Rouzer
R
NC
7
2025-01-23
True
- B001317
Rep. Brecheen, Josh [R-OK-2]
Josh
Brecheen
R
OK
2
2025-01-23
True
- S001220
Rep. Strong, Dale W. [R-AL-5]
Dale
Strong
R
AL
W.
5
2025-01-23
True
- M001211
Rep. Miller, Mary E. [R-IL-15]
Mary
Miller
R
IL
E.
15
2025-01-23
True
- W000806
Rep. Webster, Daniel [R-FL-11]
Daniel
Webster
R
FL
11
2025-01-23
True
- F000475
Rep. Finstad, Brad [R-MN-1]
Brad
Finstad
R
MN
1
2025-01-23
True
- A000055
Rep. Aderholt, Robert B. [R-AL-4]
Robert
Aderholt
R
AL
B.
4
2025-01-23
True
- F000446
Rep. Feenstra, Randy [R-IA-4]
Randy
Feenstra
R
IA
4
2025-01-23
True
- S000522
Rep. Smith, Christopher H. [R-NJ-4]
Christopher
Smith
R
NJ
H.
4
2025-01-23
True
- F000469
Rep. Fulcher, Russ [R-ID-1]
Russ
Fulcher
R
ID
1
2025-01-23
True
- F000474
Rep. Flood, Mike [R-NE-1]
Mike
Flood
R
NE
1
2025-01-23
True
- M000871
Rep. Mann, Tracey [R-KS-1]
Tracey
Mann
R
KS
1
2025-01-23
True
- H001052
Rep. Harris, Andy [R-MD-1]
Andy
Harris
R
MD
1
2025-01-23
True
- F000480
Rep. Fong, Vince [R-CA-20]
Vince
Fong
R
CA
20
2025-01-23
True
- E000071
Rep. Ellzey, Jake [R-TX-6]
Jake
Ellzey
R
TX
6
2025-01-23
True
- W000814
Rep. Weber, Randy K. Sr. [R-TX-14]
Randy
Weber
R
TX
K.
14
2025-01-23
True
- M001218
Rep. McCormick, Richard [R-GA-7]
Richard
McCormick
R
GA
7
2025-01-23
True
- M001194
Rep. Moolenaar, John R. [R-MI-2]
John
Moolenaar
R
MI
R.
2
2025-01-23
True
- O000175
Rep. Ogles, Andrew [R-TN-5]
Andrew
Ogles
R
TN
5
2025-01-23
True
- G000591
Rep. Guest, Michael [R-MS-3]
Michael
Guest
R
MS
3
2025-01-23
True
- H001077
Rep. Higgins, Clay [R-LA-3]
Clay
Higgins
R
LA
3
2025-01-23
True
- P000609
Rep. Palmer, Gary J. [R-AL-6]
Gary
Palmer
R
AL
J.
6
2025-01-23
True
- M001236
Rep. Moore, Tim [R-NC-14]
Tim
Moore
R
NC
14
2025-01-23
True
- S001229
Rep. Shreve, Jefferson [R-IN-6]
Jefferson
Shreve
R
IN
6
2025-01-23
True
- L000585
Rep. LaHood, Darin [R-IL-16]
Darin
LaHood
R
IL
16
2025-01-23
True
- F000471
Rep. Fitzgerald, Scott [R-WI-5]
Scott
Fitzgerald
R
WI
5
2025-02-11
False
- B001325
Rep. Biggs, Sheri [R-SC-3]
Sheri
Biggs
R
SC
3
2025-02-11
False
- M001212
Rep. Moore, Barry [R-AL-1]
Barry
Moore
R
AL
1
2025-09-19
False
- B001295
Rep. Bost, Mike [R-IL-12]
Mike
Bost
R
IL
12
2025-10-31
False
Health
- Abortion
2025-03-19T16:02:43Z
- Drug safety, medical device, and laboratory regulation
2025-03-19T16:02:43Z
- Health information and medical records
2025-03-19T16:02:43Z
- Health personnel
2025-03-19T16:02:43Z
- Health technology, devices, supplies
2025-03-19T16:02:43Z
- Marketing and advertising
2025-03-19T16:02:43Z
- Prescription drugs
2025-03-19T16:02:43Z
Health
2025-03-01T13:45:41Z
00
2025-01-23
Introduced in House
2025-03-17T21:26:49Z
Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025
This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.
Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.
The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.
The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

SAVE Moms and Babies Act of 2025
- Display Title
45

SAVE Moms and Babies Act of 2025
2025-02-25T05:08:20Z
- Short Title(s) as Introduced
101

SAVE Moms and Babies Act of 2025
2025-02-25T05:08:18Z
Introduced in House
IH
- Short Title(s) as Introduced
101

Support And Value Expectant Moms and Babies Act of 2025
2025-02-25T05:08:18Z
Introduced in House
IH
- Official Title as Introduced
6

To amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.
2025-02-25T05:03:23Z
Introduced in House
IH
- Introduced in House
2025-01-23T05:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-119hr685ih/xml/BILLS-119hr685ih.xml
2025-01-23
Referred to the House Committee on Energy and Commerce.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.